Good morning and welcome.
Loyce, thank you very much for those very impactful and profound words.
I have two questions. The first question I have is on drug resistance, which I think is important to discuss. I know there are initiatives right now, with the Drugs for Neglected Diseases initiative that is working very hard, especially for those diseases that have been neglected. I think there are 12 or 13. I really like the model because it's an open science model.
More importantly, on going forward and hitting your SDGs, drug resistance will play a big role when you look at the parasitic resistance or the mosquito resistance. It's one thing to supply the drugs, but if the drugs aren't effective.... Have there been any discussions on dealing with that aspect of the problem?